ショートコース

ショートコースでは、指導的かつインタラクティブに、特定のトピックに関する詳細な情報を提供します。参加者と講師が1対1でやり取りできるため、メインのプレゼンテーションでは取り上げられないような、技術的な側面についての説明が容易になります。

ショートコースは、対面のみで提供

Sunday, May 10, 2026

SC1: In silico and Machine Learning Tools for Antibody Design and Developability Predictions

Vinodh B. Kurella, PhD, Research Scientific Associate Director, Global Biologics, Takeda Pharmaceuticals, Inc.
Tanmoy Sanyal, PhD, Principal Data Scientist, Large Molecule Discovery Group, Amgen
Valentin Stanev, PhD, Associate Principal Data Scientist, AstraZeneca
Ben Williams, PhD, Research Software Engineer, Department of Statistics, University of Oxford

SC2: AI-Driven Predictive Preclinical Models: Rethinking the Role of Animal Testing

Sathy Balu-Iyer, PhD, Professor, Pharmaceutical Sciences, SUNY Buffalo
Panagiota (Pegy) Foteinou, PhD, Senior Director, Preclinical and Early Development, Bristol Myers Squibb
Jochem Gokemeijer, PhD, Distinguished Scientist Biologics, Biologics Discovery, Johnson & Johnson
Timothy Hickling, PhD, Consultant, Quasor Ltd.
Vibha Jawa, PhD, Chief Scientific Officer, Epivax Inc.
Pooja Khanna, PhD, Senior Scientist, Merck
Guilhem Richard, PhD, CTO, EpiVax Inc.

SC3: Challenges and Opportunities in Solid Tumor and Autoimmune Disease Therapeutics

Tony R. Arulanandam, DVM, PhD, CEO and Founder, Synaptimmune Therapeutics

SC4: Unlocking Immunity: Mastering Epitope Analysis and Prediction with IEDB and CEDAR Tools & Insights

Nina Blazeska, Senior Project Manager, IEDB and CEDAR Resources, La Jolla Institute for Immunology
Zeynep Kosaloglu-Yalcin, PhD, Instructor, La Jolla Institute for Immunology

SC5: Safety & Efficacy of Bispecifics and ADCs

Rakesh Dixit, PhD, DABT, CEO & President, Bionavigen Oncology, LLC; CSO, TMAB Therapeutics, Regio Biosciences

Tuesday, May 12, 2026

SC6: Developability of Bispecific Antibodies

Nimish Gera, PhD, Independent Consultant

SC7: Targeting the Target: Aligning Target and Biologic Format Biology to Achieve Desired Outcomes

Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC; Entrepreneur in Residence, FairJourney Biologics

SC8: The Dark Proteome: Unlocking Novel Targets for Next-Generation Biologics

Sudhakaran Prabakaran, Co-Founder & CEO, NonExomics

SC9: Automation in Action: Hands-on, Liquid Handling for Protein & Antibody Engineering

Curtis Walton, PhD, Director of Automation and Process Optimization, Institute for Protein Innovation

SC10: Best Practices and Advanced Applications for Label-Free Interaction Analysis in Therapeutic Antibody Discovery

Yasmina Abdiche, PhD, Senior Vice President, Exploratory Research, OmniAb Inc.

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English

早期割引き
最大 $650 OFF
12月12日までのお申込み
更新履歴
2025/12/05
スポンサー更新
2025/11/20
イベント情報更新
Download Event at a Glance
Present a Poster
2026年 プログラム

表示する:

      論題      
      日付      
Engineering
工学ストリーム
Oncology
腫瘍ストリーム
Bispecific Antibodies
多重特異性ストリーム
Immunotherpary
免疫療法ストリーム
Expression
発現ストリーム
Analytical
分析法ストリーム
Immunogenicity
免疫原性ストリーム
Emerging Modalities
新興治療ストリーム
Machine Learning Stream
機械学習ストリーム
Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEW   Nona_Biosciences_NEW